Accessibility Menu
 
Arrow-Thin-Down
S&P 500
7,259.22
+0.8%
+58.47
Arrow-Thin-Down
DJI
49,298.25
+0.7%
+356.35
Arrow-Thin-Down
NASDAQ
25,326.13
+1.0%
+258.32
Arrow-Thin-Down
Bitcoin
$81,147.00
+0.9%
+$703.57
Arrow-Thin-Down
AAPL
$284.18
+2.7%
+$7.35
Arrow-Thin-Down
AMZN
$273.71
+0.6%
+$1.66
Arrow-Thin-Down
GOOG
$384.27
+1.2%
+$4.63
Arrow-Thin-Down
META
$605.00
-0.9%
-$5.41
Arrow-Thin-Down
MSFT
$411.39
-0.5%
-$2.23
Arrow-Thin-Down
NVDA
$196.45
-1.0%
-$2.03
Arrow-Thin-Down
TSLA
$389.76
-0.7%
-$2.75
Most Active StocksDaily Stock GainersDaily Stock Losers
Takeda Pharmaceutical logo

Takeda Pharmaceutical

(NYSE) TAK

Current Price$16.54
Market Cap$52.32B
Since IPO (2010)+0%
5 Year+22%
1 Year+10%
1 Month-12%

Takeda Pharmaceutical Financials at a Glance

Market Cap

$52.32B

Revenue (TTM)

$4.49T

Net Income (TTM)

$114.75B

EPS (TTM)

$0.24

P/E Ratio

66.83

Dividend

$0.32

Beta (Volatility)

0.33 (Low)

Price

$16.54

Volume

2,132,543.732

Open

$16.57

Previous Close

$16.55

Daily Range

$16.50 - $16.63

52-Week Range

$12.99 - $18.89

TAK News

drug development pharmaceutical pharma research researchers doctors

Pharmaceutical tariffs: Which countries does the U.S. import the most from?

Jack CaporalApr 2, 2026
A person counting money in their living room.

One Ultra-Cheap High-Yield Dividend Stock to Buy

David Jagielski, CPADec 22, 2023
researcher

Better High-Yield Dividend Stock: Takeda Pharmaceutical vs. Viatris

George Budwell, PhDAug 24, 2023
dividends

2 Ultra-Cheap High-Yield Dividend Stocks to Buy Now

George Budwell, PhDAug 23, 2023
People reviewing financials on a screen.

2 Beaten-Down Dividend Stocks That Haven't Been This Cheap In More Than a Decade

David Jagielski, CPANov 16, 2022
Businessman showing chart to co-worker.

3 High-Yielding Dividend Stocks Near Their 52-Week Lows

David Jagielski, CPAOct 19, 2022
People reviewing financials on a screen.

Got $5,000? These 2 Dividend Stocks Haven't Been This Cheap in Years

David Jagielski, CPASep 14, 2022
investor expresses regret

Want Loads of Passive Income? Avoid These 3 (Very) Tempting Mistakes

Alex CarchidiJun 11, 2022
Page 1

TAK: Motley Fool Moneyball Superscore

62

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Takeda Pharmaceutical

Industry

Pharmaceuticals

Sector

Health Care

Employees

47,455

CEO

Christophe Weber, PhD

Website

www.takeda.com

Headquarters

Tokyo, 103-8668, JP

TAK Financials

Key Financial Metrics (TTM)

Gross Margin

59%

Operating Margin

10%

Net Income Margin

3%

Return on Equity

2%

Return on Capital

4%

Return on Assets

1%

Earnings Yield

1.50%

Dividend Yield

1.95%

Payout Ratio

2.77%

Stock Overview

Market Cap

$52.32B

Shares Outstanding

3.16B

Volume

2.13M

Avg. Volume

2.73M

Financials (TTM)

Gross Profit

$3.00T

Operating Income

$342.59B

EBITDA

$1.21T

Operating Cash Flow

$1.06T

Capital Expenditure

$200.79B

Free Cash Flow

$856.39B

Cash & ST Invst.

$405.59B

Total Debt

$4.52T

Takeda Pharmaceutical Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q3 2025YOY CHG

Revenue

$1.21T

+6.0%

Gross Profit

$660.35B

-9.2%

Gross Margin

54.43%

N/A

Market Cap

$52.32B

N/A

Market Cap/Employee

$1.06M

N/A

Employees

49,281

N/A

Net Income

$105.51B

+343.5%

EBITDA

$456.22B

+136.4%

Quarterly Fundamentals

Name
Q3 2025YOY CHG

Net Cash

$4.09T

+5.1%

Accounts Receivable

$758.44B

+3.2%

Inventory

$1.41T

+13.0%

Long Term Debt

$4.27T

-9.2%

Short Term Debt

$583.55B

+330.8%

Return on Assets

0.73%

N/A

Return on Invested Capital

3.59%

N/A

Free Cash Flow

$317.47B

-6.3%

Operating Cash Flow

$360.04B

-6.2%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
BDXBecton, Dickinson and Company
$144.17-1.46%
EWEdwards Lifesciences Corporation
$82.91-0.50%
CAHCardinal Health, Inc.
$197.00-0.03%
HLNHaleon plc
$9.17-0.76%

Trending Stocks

Symbol / CompanyPricePrice Chg
NOKNokia
$13.42+0.02%
POETPoet Technologies
$9.21+0.30%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares
$12.96-0.02%
CCLCarnival Corp.
$25.77+0.00%

Questions About TAK

What is the current price of Takeda Pharmaceutical?

Takeda Pharmaceutical is trading at $16.55 per share.

What is the 52-week range for Takeda Pharmaceutical?

Over the past 52 weeks, Takeda Pharmaceutical has traded between $12.99 and $18.90.

How much debt does Takeda Pharmaceutical have?

As of the most recent reporting period, Takeda Pharmaceutical reported total debt of $30.96B.

How much cash does Takeda Pharmaceutical have on hand?

Takeda Pharmaceutical reported $4.18B in cash and cash equivalents in its most recent financial results.

What is Takeda Pharmaceutical’s dividend yield?

Takeda Pharmaceutical currently has a dividend yield of 1.95%.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services